Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00387985 · ClinicalTrials.gov registry record · Phase 1

Bioequivalence Study in Healthy Volunteers

A Phase 1 study, sponsored by Bausch Health Americas.

Completed
Registry status
Phase 1
Development phase

NCT00387985: Completed Phase 1 study, sponsored by Bausch Health Americas.

NCT00387985 is a Phase 1 study that has completed, run by Bausch Health Americas. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00387985, a Phase 1 study, has completed, sponsored by Bausch Health Americas.

COMPLETED
Registry status
Phase 1
Development phase

Study Summary

Primary: To determine the bioequivalence between the new formulation and the current formulation of the investigational drug, MOA-728.

Interventions

  • DRUG MOA-728

Trial Details

FieldValue
Start Date 2006-08
Est. Completion 2006-09
Phase Phase 1
Bausch Health Americas

168 total trials

What the finished NCT00387985 record still lists

NCT00387985 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 0 conditions, and to 1 intervention - of which MOA-728 is the first listed.

NCT00387985 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00387985 about?

NCT00387985 is a clinical study titled "Bioequivalence Study in Healthy Volunteers". Primary: To determine the bioequivalence between the new formulation and the current formulation of the investigational drug, MOA-728.

What is the current status of trial NCT00387985?

This trial is currently completed. It is a Phase 1 study. The study started on 2006-08. Estimated completion is 2006-09.

What interventions are being tested in trial NCT00387985?

The interventions under investigation include: MOA-728 (DRUG).

Who is sponsoring clinical trial NCT00387985?

This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00387985, the US trial registry maintained by the National Library of Medicine. NCT00387985 (unsized enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.